Acadia Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Acadia Pharmaceuticals Inc
CIK #0001070494
EDGAR Form CIK 2011 - 2025
10-K [0001070494]
10-Q [0001070494]
3 [0001070494]
4 [0001070494]
8-K [0001070494]
D [0001070494]
SC 13D [0001070494]
SC 13G [0001070494]
Form 13D/13G Filer Form 13D/13G Subject Filed
RTW Investments LP Acadia Pharmaceuticals Inc [2024-02-14]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2022-02-14]
BlackRock Inc Acadia Pharmaceuticals Inc [2022-02-04]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2020-02-14]
Point72 Asset Management LP Acadia Pharmaceuticals Inc [2018-06-18]
Janus Henderson Group PLC Acadia Pharmaceuticals Inc [2018-02-12]
BlackRock Inc Acadia Pharmaceuticals Inc [2018-02-01]
Vanguard Group Inc Acadia Pharmaceuticals Inc [2016-02-10]
Price T Rowe Associates Inc /MD/ Acadia Pharmaceuticals Inc [2015-02-12]
Viking Global Investors LP Acadia Pharmaceuticals Inc [2014-05-05]
View All
Form 3/4/5 Subject 2011 - 2025
Acadia Pharmaceuticals Inc
Schneyer Mark C.
Brege Laura
Daly James M
Garofalo Elizabeth A
Baker Bros. Advisors (GP) LLC
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Brothers Life Sciences LP
View All
Terms | Privacy | Guide
tony@aum13f.com